Latest News

Cannabis constituent has no effect on multiple sclerosis progression, study shows

The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis, shows that there is no evidence to suggest this; although benefits were noted for those at the lower end of the disability scale.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Study sheds light on homebuyer types

  • Facilitated intervention can improve quality of life for breast cancer survivors

  • 'Religiously integrated' psychotherapy is effective for depression

  • Neuroscientists call for immediate action to determine the dangers and benefits of cognitive-enhancing drug use in healthy people

  • Older workers bring valuable knowledge to the job

  • Common cholesterol drug stimulates the same receptors as marijuana

  • How we hear distance: Echoes are essential for humans to perceive how far away a sound is

  • Presence of heart pouch may explain strokes of unknown origin, study finds

  • Researchers 'smell' new receptors that could underlie the many actions of the anesthetic drug ketamine

  • Phone counseling reduces pain, disability after back surgery

  •